These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 20596751)
1. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism. Johnson MD; O'Connell M; Pilcher W J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid stimulates leptomeningeal and meningioma cell proliferation and activation of STAT3. Johnson MD; O'Connell M; Facik M; Maurer P; Jahromi B; Pilcher W J Neurooncol; 2012 Mar; 107(1):121-31. PubMed ID: 21971737 [TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis. Johnson MD; O'Connell MJ; Walter K BMC Complement Altern Med; 2013 Nov; 13():303. PubMed ID: 24188277 [TBL] [Abstract][Full Text] [Related]
4. MKP-3 regulates PDGF-BB effects and MAPK activation in meningioma cells. Johnson MD; Reeder JE; O'Connell M J Clin Neurosci; 2015 Apr; 22(4):752-7. PubMed ID: 25698542 [TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. Johnson MD; O'Connell MJ; Pilcher W; Reeder JE J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046 [TBL] [Abstract][Full Text] [Related]
6. Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. Johnson MD; Okedli E; Woodard A; Toms SA; Allen GS J Neurosurg; 2002 Sep; 97(3):668-75. PubMed ID: 12296652 [TBL] [Abstract][Full Text] [Related]
7. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814 [TBL] [Abstract][Full Text] [Related]
8. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas. Johnson MD; O'Connell M; Vito F; Bakos RS J Neurooncol; 2009 Apr; 92(2):129-36. PubMed ID: 19034385 [TBL] [Abstract][Full Text] [Related]
9. CIP2A and PP2A in human leptomeninges, arachnoid granulations and meningiomas. Johnson MD; Reeder JE; O'Connell M; Woodford M; Walter K J Clin Neurosci; 2014 Dec; 21(12):2228-32. PubMed ID: 25012485 [TBL] [Abstract][Full Text] [Related]
10. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190 [TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor expression and stimulation in human meningiomas. Black PM; Carroll R; Glowacka D; Riley K; Dashner K J Neurosurg; 1994 Sep; 81(3):388-93. PubMed ID: 8057146 [TBL] [Abstract][Full Text] [Related]
12. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. Johnson MD; Woodard A; Kim P; Frexes-Steed M J Neurosurg; 2001 Feb; 94(2):293-300. PubMed ID: 11213968 [TBL] [Abstract][Full Text] [Related]
13. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Mawrin C; Sasse T; Kirches E; Kropf S; Schneider T; Grimm C; Pambor C; Vorwerk CK; Firsching R; Lendeckel U; Dietzmann K Clin Cancer Res; 2005 Jun; 11(11):4074-82. PubMed ID: 15930342 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. Pfister C; Pfrommer H; Tatagiba MS; Roser F Br J Cancer; 2012 Nov; 107(10):1702-13. PubMed ID: 23047550 [TBL] [Abstract][Full Text] [Related]
16. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
17. Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas. Johnson MD; Shaw AK; O'Connell MJ; Sim FJ; Moses HL J Neurooncol; 2011 Jun; 103(2):277-85. PubMed ID: 20853018 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Kim TJ; Yun YP Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid induces G0/G1 cell cycle arrest and cell migration inhibition via suppressing PDGF receptor β tyrosine phosphorylation and Rac1 activity in rat aortic smooth muscle cells. Liu Y; Li W; Ye C; Lin Y; Cheang TY; Wang M; Zhang H; Wang S; Zhang L; Wang S J Atheroscler Thromb; 2010 Sep; 17(9):901-13. PubMed ID: 20543524 [TBL] [Abstract][Full Text] [Related]
20. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. Yellaturu CR; Bhanoori M; Neeli I; Rao GN J Biol Chem; 2002 Oct; 277(42):40148-55. PubMed ID: 12171932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]